Browse Related Topics For:

Off-Label Promotion

46
Pharmaceutical
33
FDA
33
Off-Label Use
25
FDCA
24
Prescription Drugs
22
Marketing
17
First Amendment
16
Free Speech
15
Commercial Speech
13
False Claims Act
11
Misbranding
9
Medical Devices
9
Pharmaceutical Manufacturers
8
Healthcare
8
Qui Tam
7
DOJ
7
Whistleblowers
5
Drug Manufacturers
5
Johnson & Johnson
5
Medicare
4
Anti-Kickback Statute
4
FCA
4
Fraud
4
Hospitals
4
Physicians
4
Popular
3
Caronia
3
Draft Guidance
3
Enforcement
3
InterMune
3
Kickbacks
3
Life Sciences
3
RICO
3
SCOTUS
2
Biotechnology
2
Choice-of-Law
2
Class Action
2
Class Certification
2
Compliance
2
Criminal Prosecution
2
Enforcement Actions
2
FCPA
2
GlaxoSmithKline
2
Health Care Providers
2
HHS
2
Insurers
2
Labeling
2
Medicaid
2
Medicare Part D
2
Medtronic
2
Novartis
2
Orphan Drugs
2
Pleading Standards
2
Predominance Requirement
2
Relators
2
SEC
2
Settlement
2
Wire Fraud
1
340B
1
Advertising
1
Affordable Care Act
1
Amazon
1
Amgen
1
Amgen Inc. v Connecticut Retirement Plans
1
ANDA
1
Anti-Money Laundering
1
Appeals
1
Arbitration
1
Below-Cost Pricing
1
Bone Grafts
1
Bristol-Myers Squibb
1
Cephalon
1
CFPB
1
Civil Monetary Penalty
1
Contract Drafting
1
Criminal Conspiracy
1
Cross-Border Transactions
1
Declination
1
Discovery
1
Dismissals
1
Durable Medical Equipment
1
Expert Witness
1
False Advertising
1
False Billing
1
Fifth Amendment
1
First-to-File
1
Foreign Financial Accounts
1
FTC
1
FTC v Actavis
1
Healthcare Facilities
1
Healthcare Professionals
1
Home Health Care
1
Honest Services Fraud
1
Hospice
1
HRSA
1
Humana
1
Illegal Gratuities
1
Indictments
1
International Arbitration
1
Interstate Commerce
1
Inversions
1
Janssen Pharmaceuticals
1
Kaiser Permanente
1
Kapidex
1
Leave to Amend
1
Libor
1
License Agreements
1
Manufacturers
1
Merck
1
Millennium Pharmaceuticals
1
Misrepresentation
1
Motion to Compel
1
Nursing Homes
1
OIG
1
OPDP
1
Par Pharmaceutical
1
Patient Recruiters
1
Pfizer
1
Pleadings
1
Preemption
1
Professional Liability
1
Proposed Amendments
1
Public Disclosure
1
Putative Class Actions
1
Records Exception
1
Regulatory Standards
1
Rule 23
1
Safe Harbors
1
Schering-Plough
1
Sealed Records
1
Securities Fraud
1
Social Media
1
Solvay Pharmaceuticals
1
Statute of Limitations
1
Strategic Enforcement Plan
1
Strict Liability
1
Takeda Pharmaceuticals
1
Trademarks
1
Travelers
1
TRICARE
1
Unfair or Deceptive Trade Practices
1
Vascular Solutions